Anaplastic Oligoastrocytoma

Development of Secondary Anaplastic Oligoastrocytoma after Matched Unrelated Bone Marrow Transplantation in a Child with Acute Myeloid Leukemia

Acta Haematologica ◽

10.1159/000070970 ◽

2003 ◽

Vol 109 (4) ◽

pp. 196-198 ◽

Cited By ~ 1

Author(s):

Soumya Panigrahi ◽

Mayukh Das ◽

Dalia Stagler ◽

Shlomi Konstantini ◽

Moshe Gmori ◽

...

Keyword(s):

Bone Marrow ◽

Acute Myeloid Leukemia ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Myeloid Leukemia ◽

Unrelated Bone Marrow Transplantation ◽

Anaplastic Oligoastrocytoma ◽

Acute Myeloid

Download Full-text

Solitary “aggressive” leptomeningeal anaplastic oligoastrocytoma

Revue Neurologique ◽

10.1016/j.neurol.2015.06.005 ◽

2015 ◽

Vol 171 (11) ◽

pp. 796-798

Author(s):

C. Joubert ◽

A. Faivre ◽

N. Desse ◽

A. Dagain

Keyword(s):

Anaplastic Oligoastrocytoma

Download Full-text

Neoadjuvant temozolomide followed by complete resection of a 1p- and 19q-deleted anaplastic oligoastrocytoma: Case study

Neuro-Oncology ◽

10.1215/s1152851704000560 ◽

2005 ◽

Vol 7 (1) ◽

pp. 97-100 ◽

Cited By ~ 12

Author(s):

Alfredo D. Voloschin ◽

David N. Louis ◽

Garth R. Cosgrove ◽

Tracy T. Batchelor

Keyword(s):

Complete Resection ◽

Anaplastic Oligoastrocytoma

Download Full-text

Comprehensive mutation analysis in NRG Oncology/RTOG 9813: A phase III trial of RT + TMZ vs RT + nu for anaplastic astrocytoma and mixed anaplastic oligoastrocytoma (Astrocytoma Dominant).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.2016 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 2016-2016 ◽

Cited By ~ 5

Author(s):

Erica Hlavin Bell ◽

Joseph P McElroy ◽

Jessica Fleming ◽

Cynthia Dawn Timmers ◽

Arup R Chakraborty ◽

...

Keyword(s):

Mutation Analysis ◽

Anaplastic Astrocytoma ◽

Phase Iii ◽

Phase Iii Trial ◽

Anaplastic Oligoastrocytoma

Download Full-text

Focal seizure induced by preoperative navigated transcranial magnetic stimulation in a patient with anaplastic oligoastrocytoma

Brain Stimulation ◽

10.1016/j.brs.2016.12.006 ◽

2017 ◽

Vol 10 (2) ◽

pp. 331-332 ◽

Cited By ~ 3

Author(s):

Stefan Jun Groiss ◽

Carlos Trenado ◽

Michael Sabel ◽

Alfons Schnitzler ◽

Lars Wojtecki

Keyword(s):

Transcranial Magnetic Stimulation ◽

Magnetic Stimulation ◽

Focal Seizure ◽

Navigated Transcranial Magnetic Stimulation ◽

Anaplastic Oligoastrocytoma

Download Full-text

Study of Histomolecular Classification of Glioma-Integrating Histology and Molecular Analysis in the Diagnosis of Brain Tumors

Indian Journal of Neurosurgery ◽

10.1055/s-0038-1668469 ◽

2018 ◽

Vol 07 (02) ◽

pp. 129-134

Author(s):

Shameen Devi ◽

Michelle De Padua ◽

Iravathy Kalal

Keyword(s):

Anaplastic Astrocytoma ◽

Idh1 Mutation ◽

Tumor Type ◽

Diffuse Astrocytoma ◽

Isocitrate Dehydrogenase 1 ◽

Anaplastic Oligoastrocytoma ◽

Diffuse Gliomas ◽

Grade Ii ◽

Classification Of Gliomas

Abstract Introduction The updated 2016 classification of gliomas incorporates well-established molecular parameters into the classification of diffuse gliomas, taking into account isocitrate dehydrogenase 1 (IDH1) mutation, α-thalassemia/mental retardation syndrome X-linked (ATRX) loss, and 1p/19q co-deletion. Aim and Objectives To study IDH1 and ATRX mutations in gliomas, 1p/19q co-deletion by fluorescent in situ hybridization (FISH) in oligodendroglioma, and to correlate IDH1, ATRX, and 1p/19q with tumor type and grade. Material and Methods Total 73 cases of gliomas were diagnosed on histology and graded as astrocytoma (grades 2–4), oligodendroglioma (grades 2–3), and oligoastrocytoma (grades 2–3) by two pathologists independently. IDH mutation and ATRX expression were analyzed using immunohistochemistry in all cases whereas 1p/19q co-deletion was studied using FISH in cases with oligodendroglioma and oligoastrocytoma morphology. Results Total 48 cases of astrocytoma, 9 cases of oligoastrocytoma, and 16 cases of oligodendroglioma were included. The maximum number of IDH1 mutation cases were seen in diffuse astrocytoma (7/10; 70%) as compared with anaplastic astrocytoma (5/15; 33.33%), glioblastoma multiforme (GBM) (3/23; 13.04%) grade II oligoastrocytoma (3/6; 50%), anaplastic oligoastrocytoma (2/3; 66.67%), and oligodendroglioma grade II (7/10; 70%). ATRX loss was seen in diffuse astrocytoma grade II (6/10; 60%), anaplastic astrocytoma (6/15; 40%), oligoastrocytoma grade II (2/6; 33.33%), and anaplastic oligoastrocytoma (1/3; 33.33%). 1p/19q co-deletion was seen in oligoastrocytoma (2/2; 100%), anaplastic oligoastrocytoma (1/2; 50%), oligodendroglioma (3/4; 75%), and anaplastic oligodendroglioma (1/3; 33.33%). Six of the seven cases with 1p/19q co-deletion also showed IDH1 mutation. One of seven 1p/19q co-deleted cases had loss of expression of ATRX. Conclusion Incorporation of IDH1 mutation, ATRX loss, and 1p/19q co-deletion molecular studies help in a more accurate diagnosis and classification of gliomas.

Download Full-text